Biocon’s Kiran Mazumdar-Shaw identifies successor

Kiran Mazumdar-Shaw, Executive Chairperson, Biocon Ltd, has set in motion a succession plan for the biotechnology company and has named her niece Claire Mazumdar as her chosen successor.

Listen to this article

Shaw has mentioned this in her interview with Fortune India.

“Not planning to hang up my boots for a while! Claire will gradually transition into my role in time,” Shaw said in a post on X.

Shaw a first generation entrepreneur founded Biocon in 1978. She started her biotech journey in 1978 from her garage in India.

Claire Mazumdar is the founding CEO of Bicara Therapeutics, a Nasdaq listed company.

Also read: https://industrialeconomist.com/major-leadership-rejig-at-biocon/

Latest

Renewed West Asia tensions, weather shocks pose risk to growth: RBI Governor

“The West Asia conflict continues to challenge the global...

RBI expects FY2027 growth at 6.7%, inflation at 5%

The first quarter GDP is expected at 7 per...

RBI keeps repo rate unchanged, awaits more clarity

“Any such action would also have to consider the...

RBI decision: Likely status quo, all eyes on future direction

The domestic economic fundamentals remain resilient, but inflationary pressures...

Newsletter

Don't miss

Renewed West Asia tensions, weather shocks pose risk to growth: RBI Governor

“The West Asia conflict continues to challenge the global...

RBI expects FY2027 growth at 6.7%, inflation at 5%

The first quarter GDP is expected at 7 per...

RBI keeps repo rate unchanged, awaits more clarity

“Any such action would also have to consider the...

RBI decision: Likely status quo, all eyes on future direction

The domestic economic fundamentals remain resilient, but inflationary pressures...

The Sustainable and Scalable World of Net Zero

As I reflect on the enthralling path of Environmental...

Renewed West Asia tensions, weather shocks pose risk to growth: RBI Governor

“The West Asia conflict continues to challenge the global economy by disrupting key trade routes and supply chains, amplifying market volatility and depressing business...

RBI expects FY2027 growth at 6.7%, inflation at 5%

The first quarter GDP is expected at 7 per cent, while it is expected to be 6.4 per cent in the second quarter. RBI now...

RBI keeps repo rate unchanged, awaits more clarity

“Any such action would also have to consider the need for recalibration of policy rates in line with the evolving growth-inflation dynamics, especially the...